Search Results 1001-1010 of 16371 for monoclonal antibody

1. A Study of Obinutuzumab to Evaluate the Safety and Tolerability in Hypersensitized Adult Participants with End Stage Renal Disease Awaiting Transplantation - Mayo Clinic

   ... antibody (HBcAb) or seropositivity ... History of severe allergic or anaphylactic reactions to monoclonal antibodies or components of obinutuzumab infusion ...

2. Study Evaluating the Safety and Effectiveness of JCARH125 in Subjects with Relapsed and/or Refractory Multiple Myeloma (EVOLVE) - Mayo Clinic

   Monoclonal antibodies (anti-CD38 and anti-SLAMF7 antibody) within 4 weeks prior to leukapheresis;; Any other systemic therapy approved for the treatment of ...

3. Haemophilus b polysaccharide vaccine (intramuscular route, injection route) - Mayo Clinic

   Children who developed Hib disease when 24 months of age or older do not need to be immunized, since most children in this age group will develop antibodies ...

4. A Study to Evaluate Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection - Mayo Clinic

   Bezlotoxumab (CDI monoclonal antibodies) if received within the last year. Disease symptoms (e.g., diarrhea) caused by a confirmed intestinal pathogen other ...

5. A Study of the Safety and Effectiveness of QPI-1002 for the Prevention of Delayed Graft Function in Transplant Recipients from Older Kidney Donors who have Died - Mayo Clinic

   ... monoclonal antibodies per center standard of care. Must be up-to-date on ... Has a positive T- or B-cell flow cross-match AND donor specific anti-HLA antibody ...

6. A Safety Study of SYNT001 in Subjects With Chronic, Stable Warm Autoimmune Hemolytic Anemia (WAIHA) - Mayo Clinic

   Positive for human immunodeficiency virus (HIV) or hepatitis C antibody. Positive for hepatitis B surface antigen. Splenectomy within 3 months of screening ...

7. Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM - Mayo Clinic

   Active secondary malignancy; Prior anti-cancer monoclonal antibody within 4 weeks prior to first dose of study drug, or not recovered from adverse effects ...

8. A Study to Evaluate the Safety and Effectiveness of Intratumoral and Intravenous Injection of Vesicular Stomatitis Virus Expressing Human Interferon Beta, and Tyrosinase Related Protein 1 (VSV-IFNb-TYRP1) in Patients with Metastatic Ocular Melanoma and Previously Treated Patients with Unresectable Stage III/IV Cutaneous Melanoma - Mayo Clinic

   Prior immunotherapy (monoclonal antibodies) ≤ 3 weeks prior to registration; ... Known history of Human Immunodeficiency Virus (HIV) (HIV 1/2 antibodies).

9. Coronavirus disease 2019 (COVID-19) - Doctors and departments - Mayo Clinic

   COVID-19 antibody testing · COVID-19 tests · Extracorporeal membrane oxygenation (ECMO). Show more associated procedures. News from Mayo Clinic. Mayo Clinic ...

10. Immune Predictors of Response to Pembrolizumab Therapy in Stage IV Melanoma Patients - Mayo Clinic

    Has had a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study Day 1 or who has not recovered (i.e., ≤ Grade 1 or at baseline) from ...